Pregled bibliografske jedinice broj: 348020
Long-lasting antinociceptive effect of botulinum toxin type a in experimental diabetic neuropathy: surprising bilateral effect after unilateral injection
Long-lasting antinociceptive effect of botulinum toxin type a in experimental diabetic neuropathy: surprising bilateral effect after unilateral injection // Abstracts of the 39th International Danaube Symposium for Neurological Sciences and Continuing Education ; u: Journal of Neural Transmission 114 (2007) (S) / Riederer, Peter ; Gerlach, Manfred (ur.).
Beč : New York (NY): Springer, 2007. str. 129-129 (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 348020 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Long-lasting antinociceptive effect of botulinum toxin type a in experimental diabetic neuropathy: surprising bilateral effect after unilateral injection
Autori
Bach-Rojecky, Lidija ; Šalkovic-Petrišić, Melita ; Lacković, Zdravko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the 39th International Danaube Symposium for Neurological Sciences and Continuing Education ; u: Journal of Neural Transmission 114 (2007) (S)
/ Riederer, Peter ; Gerlach, Manfred - Beč : New York (NY) : Springer, 2007, 129-129
Skup
39th International Danaube Symposium for Neurological Sciences and Continuing Education
Mjesto i datum
Würzburg, Njemačka, 02.06.2007. - 05.06.2007
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
botulinum toxin; pain; nociception
Sažetak
Recently we found that peripheral application of botulinum toxin type A (BTX-A) reduces hypersensitivity in rats with the partial sciatic nerve transection as a classical model of neuropathy (Bach-Rojecky et al., J. Neural. Transm. 2005 ; 112: 215-219). In human the most common cause of painful neuropathy is diabetes mellitus. In present experiments in rats with streptozotocin-induced diabetes we investigated the possibility that BTX-A has antinociceptive effect in painful neuropathy. Male Wistar rats (250-300 g) were made diabetic by a single subcutaneous (s.c.) injection of streptozotocin (80 mg/kg b.w.). Animals with a tail-vein blood-glucose concentration of above 15 mmol/l were considered diabetic. Sensitivity to mechanical stimuli was measured bilaterally with the paw-pressure test. Measurements started 3 weeks following streptozotocin or saline injection. Only the animals with mechanical thresholds lower for at least for 25% compared to saline-treated group were considered neuropathic and were than subjected to unilateral peripheral (in the plantar surface of the right hindpaws) BTX-A (3, 5 and 7 U/kg) or saline treatment. Mechanical sensitivity was tested bilaterally on day 1, 5, 15 and 28 following BTX-A injection. Statistical analysis was performed with Newman-Keuls post hoc test. BTX-A 5 and 7 U/kg reduced the mechanical hypersensitivity in diabetic animals compared to the saline-treated diabetic control (109.6 3 g for BTX-A vs. 86.2 5.1 g for control ; p<0.01). The antinociceptive effect was evident on day 5 and was significant till the day 15. Surprisingly, BTX-A reduced the mechanical hypersensitivity on the contralateral hindpaw too. Single peripheral BTX-A injection has a long-lasting bilateral antinociceptive effect in experimental diabetic neuropathy. Surprisingly, after unilateral injection, antinociceptive effect is achieved bilaterally. This observation questions suggested peripheral mechanism of antinociceptive action of BTX-A. Supported by Croatian Ministry of Education, Science and Sport (Project number:108-1080003-0001 ; to Z. Lackovic), and Deutscher Akademischer Austausch Dienst (DAAD)
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
108-1080003-0001 - NEUROTRANSMITORI I NOVI MEHANIZMI DJELOVANJA LIJEKOVA I OTROVA (Lackovic, Zdravko, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE